Updated Jul 16, 2026
Cobo Marc has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Marc Cobo is listed in SEC filings as associated with BridgeBio Oncology Therapeutics, Inc. as of July 6, 2026. Public biographical details beyond this affiliation are not provided in the context you supplied. BridgeBio Oncology Therapeutics, Inc. operates within the BridgeBio Pharma family, focusing on oncology programs.
| Role | Insider |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | BBOT | BridgeBio Oncology Therapeutics, Inc. | F — Tax withholding / forfeiture | 125 | $7.80 | $975 |
Marc Cobo is listed in SEC filings as associated with BridgeBio Oncology Therapeutics, Inc. as of July 6, 2026. Public biographical details beyond this affiliation are not provided in the context you supplied. BridgeBio Oncology Therapeutics, Inc. operates within the BridgeBio Pharma family, focusing on oncology programs.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cobo Marc profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.